HWAM
AUPH icon

Hennion & Walsh Asset Management’s Aurinia Pharmaceuticals AUPH Stock Holding History

Hennion & Walsh Asset Management’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-75,787
Closed -$380K – 844
2024
Q1 		$380K Buy
75,787
+5,043
+7% +$34.2K 0.02% 639
2023
Q4 		$636K Buy
70,744
+8,658
+14% +$71.3K 0.04% 511
2023
Q3 		$482K Buy
62,086
+2,465
+4% +$24.1K 0.03% 529
2023
Q2 		$577K Sell
59,621
-99,888
-63% -$1.04M 0.03% 475
2023
Q1 		$1.75M Sell
159,509
-5,302
-3% -$46.7K 0.11% 232
2022
Q4 		$712K Sell
164,811
-136,874
-45% -$794K 0.04% 409
2022
Q3 		$2.27M Buy
301,685
+3,637
+1% +$31.5K 0.15% 178
2022
Q2 		$3M Buy
298,048
+32,450
+12% +$363K 0.19% 140
2022
Q1 		$3.29M Sell
265,598
-4,407
-2% -$68.1K 0.17% 158
2021
Q4 		$6.17M Sell
270,005
-10,916
-4% -$259K 0.3% 89
2021
Q3 		$6.22M Buy
280,921
+24,378
+10% +$387K 0.33% 71
2021
Q2 		$3.33M Buy
256,543
+82,983
+48% +$1.06M 0.18% 161
2021
Q1 		$2.25M Buy
+173,560
New +$2.52M 0.14% 208

Other funds holding AUPH

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Hennion & Walsh Asset Management's AUPH Position: Q2 2024 in Review

Hennion & Walsh Asset Management sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2024, closing a stake of 75,787 shares — an estimated $380K sold.

Hennion & Walsh Asset Management first reported a position in AUPH in Q1 2021 and held it in 13 quarters. The position peaked at $6.22M in Q3 2021. 171 funds tracked by Wall St. Rank hold AUPH as of Q2 2024.

  • Hennion & Walsh Asset Management reported no remaining Aurinia Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 75,787 Aurinia Pharmaceuticals shares in Q2 2024, an estimated $380K.
  • Hennion & Walsh Asset Management first reported a position in Aurinia Pharmaceuticals in Q1 2021 and held it in 13 quarters.
  • Hennion & Walsh Asset Management's Aurinia Pharmaceuticals position peaked at $6.22M in Q3 2021.
  • 171 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2024, filed 19 Jul 2024.